2024 - NCI Bottom Line: A Blog about Grants and More
-
NCI's Fiscal Year 2025 Interim Paylines Announced
In this edition of the Bottom Line blog, NCI Director Dr. Kimryn Rathmell shares the interim grant funding policies that will be in place until FY25 funding is finalized.
-
A Commitment to Early-Stage Investigators and Community Engagement
NCI’s Fiscal Year 2026 Annual Plan and Budget Proposal highlights how increasing the funding for the cancer research enterprise will allow us to tackle the opportunities before us and help all people live longer, healthier lives. In this blog, Dr. Diane Palmieri highlights NCI’s commitment to early-stage investigators and the importance of engaging every person to end cancer as we know it.
-
NCI’s Commitment to Advancing Cancer Training
In this edition of the Bottom Line blog, NCI Center for Cancer Training Director Dr. Oliver Bogler discusses recent trends in funding for NCI's training portfolio, highlights enhancements to the Pathway to Independence Award, and introduces a new career development award for clinical scientists.
-
Fiscal Year 2024 Appropriation Brings Clarity and Difficult Choices
In this edition of the Bottom Line blog, NCI Director Dr. W. Kimryn Rathmell discusses NCI’s fiscal year 2024 appropriation from Congress, which increases the base budget, but also reflects the end of dedicated funding for the Cancer Moonshot. The budget allows NCI to prioritize funding for new grants—particularly to early-stage investigators, training mechanisms, and Cancer Centers—while limiting the impact on continuing grants.
-
A Brief Message for Bottom Line Readers, from NCI Director Dr. Rathmell
In this edition of the Bottom Line blog, NCI Director Dr. W. Kimryn Rathmell describes her commitment to fostering open communication with the cancer community and shares information about a live social media event on February 22, 2024, at 11:30 a.m. ET.